For the quarter ending 2026-03-31, FEED had -$1,989K decrease in cash & cash equivalents over the period. -$4,329K in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 |
|---|---|---|
| Net loss | -3,822 | -18,185 |
| Depreciation and amortization | 217 | 897 |
| Noncash interest expense | 30 | 239 |
| Other | - | 19 |
| Changes in deferred income taxes, net | - | -373 |
| Change in fair value of warrant liability | -17 | 6,204 |
| Impairment of goodwill and long-lived assets | - | 11,154 |
| Issuance cost allocated to warrant liability | - | 1,420 |
| Trade receivable | 43 | 179 |
| Prepaid expenses and other accounts receivable | 943 | 96 |
| Inventory | -71 | -249 |
| Trade payables | -13 | 552 |
| Other accounts payable and accrued expenses | 357 | 1,025 |
| Deferred revenue | -175 | 160 |
| Operating right-of-use asset | -11 | -71 |
| Operating lease liabilities | -19 | -85 |
| Accrued severance pay, net | - | -36 |
| Net cash used in operating activities | -4,312 | -9,372 |
| Cash acquired in envue merger | - | 148 |
| Purchase of property and equipment | 17 | 60 |
| Net cash (used in) provided by investing activities | -17 | 88 |
| Proceeds from the issuance of common stock, preferred stock and warrants, net | 3,900 | 19,089 |
| Repurchase of series x preferred stock | 1,560 | 5,000 |
| Proceeds from issuance of notes payable to related party | - | 1,300 |
| Payments of note payable to related party | - | 1,300 |
| Payments of short-term loan to related party | - | 1,777 |
| Proceeds from issuance of short-term loan payable | - | 360 |
| Proceeds from exercise of warrants | - | 102 |
| Other | - | 12 |
| Net cash provided by financing activities | 2,340 | 12,786 |
| Net decrease in cash, cash equivalents and restricted cash | -1,989 | 3,502 |
| Cash, cash equivalents and restricted cash at beginning of period | 4,254 | 752 |
| Cash, cash equivalents and restricted cash at end of period | 2,265 | 4,254 |
ENvue Medical, Inc. (FEED)
ENvue Medical, Inc. (FEED)